Susquehanna International Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,651,500
| Closed | -$164M | – | 11308 |
|
|
2019
Q3 | $164M | Buy |
1,651,500
+437,246
| +36% | +$41.5M | 0.06% | 290 |
|
|
2019
Q2 | $112M | Buy |
1,214,254
+965,461
| +388% | +$91.7M | 0.04% | 380 |
|
|
2019
Q1 | $23.5M | Sell |
248,793
-2,100,318
| -89% | -$184M | 0.01% | 1073 |
|
|
2018
Q4 | $151M | Buy |
2,349,111
+1,446,509
| +160% | +$107M | 0.06% | 274 |
|
|
2018
Q3 | $80.8M | Sell |
902,602
-863,903
| -49% | -$76.3M | 0.03% | 505 |
|
|
2018
Q2 | $140M | Sell |
1,766,505
-2,192,461
| -55% | -$182M | 0.05% | 316 |
|
|
2018
Q1 | $353M | Buy |
3,958,966
+3,183,696
| +411% | +$306M | 0.13% | 117 |
|
|
2017
Q4 | $80.9M | Buy |
775,270
+638,190
| +466% | +$72M | 0.03% | 493 |
|
|
2017
Q3 | $20M | Sell |
137,080
-25,228
| -16% | -$3.44M | 0.01% | 1228 |
|
|
2017
Q2 | $21.1M | Sell |
162,308
-72,354
| -31% | -$8.87M | 0.01% | 1135 |
|
|
2017
Q1 | $29.2M | Buy |
234,662
+230,546
| +5,601% | +$27.6M | 0.01% | 830 |
|
|
2016
Q4 | $476K | Sell |
4,116
-251,666
| -98% | -$28M | ﹤0.01% | 7099 |
|
|
2016
Q3 | $26.7M | Buy |
255,782
+252,344
| +7,340% | +$27.3M | 0.01% | 830 |
|
|
2016
Q2 | $339K | Sell |
3,438
-395,535
| -99% | -$40.9M | ﹤0.01% | 6760 |
|
|
2016
Q1 | $39.9M | Sell |
398,973
-1,023,380
| -72% | -$105M | 0.02% | 614 |
|
|
2015
Q4 | $170M | Sell |
1,422,353
-609,406
| -30% | -$70.5M | 0.08% | 211 |
|
|
2015
Q3 | $220M | Sell |
2,031,759
-819,015
| -29% | -$102M | 0.1% | 185 |
|
|
2015
Q2 | $330M | Buy |
2,850,774
+2,167,887
| +317% | +$248M | 0.14% | 109 |
|
|
2015
Q1 | $78.7M | Sell |
682,887
-600,564
| -47% | -$71.8M | 0.04% | 459 |
|
|
2014
Q4 | $144M | Sell |
1,283,451
-751,294
| -37% | -$79.2M | 0.06% | 299 |
|
|
2014
Q3 | $193M | Sell |
2,034,745
-890,815
| -30% | -$80.4M | 0.07% | 224 |
|
|
2014
Q2 | $251M | Buy |
2,925,560
+51,662
| +2% | +$3.93M | 0.11% | 141 |
|
|
2014
Q1 | $201M | Buy |
2,873,898
+1,227,782
| +75% | +$97.2M | 0.09% | 181 |
|
|
2013
Q4 | $139M | Sell |
1,646,116
-714,718
| -30% | -$56.6M | 0.06% | 246 |
|
|
2013
Q3 | $182M | Sell |
2,360,834
-116,736
| -5% | -$8.18M | 0.1% | 159 |
|
|
2013
Q2 | $145M | Buy |
+2,477,570
| New | +$149M | 0.08% | 183 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Susquehanna International Group's CELG Position: Q4 2019 in Review
Susquehanna International Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,651,500 shares — an estimated $164M sold.
Susquehanna International Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $353M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Susquehanna International Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 1,651,500 Celgene Corp shares in Q4 2019, an estimated $164M.
- Susquehanna International Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Susquehanna International Group's Celgene Corp position peaked at $353M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.